Core Viewpoint - The company is expected to achieve significant growth in net profit for 2025, with projections indicating a year-on-year increase of 46.89% to 57.62% for net profit attributable to shareholders, and 56.03% to 66.07% for net profit after deducting non-recurring gains and losses [1] Group 1: Financial Performance - For 2025, the company forecasts a net profit attributable to shareholders of 1.78 to 1.91 billion yuan, and a net profit after deducting non-recurring gains and losses of 1.71 to 1.82 billion yuan [1] - In Q4 2025, the company anticipates a net profit of 0.31 to 0.44 billion yuan, representing a year-on-year growth of 6.1% to 50.2% [1] - The projected revenue for 2025 to 2027 is 17.04 billion yuan, 18.63 billion yuan, and 22.66 billion yuan, with year-on-year growth rates of 9.53%, 9.36%, and 21.63% respectively [2] Group 2: Operational Strategy - The company focuses on high-end manufacturing, energy optimization, and lean management to achieve significant cost reductions and efficiency improvements [1] - The management team actively monitors raw material market trends to capitalize on procurement opportunities, effectively lowering the cost of non-GMO soybean procurement [1] - New high-margin production capacities are expected to come online by the end of 2026, contributing to revenue growth and improving product structure [1] Group 3: Future Projections - The company expects to launch a 30,000-ton soybean textured protein project and a high-end soybean protein production line by December 2026 and June 2027, respectively [1] - The new products, including textured protein and high-end soybean protein, are anticipated to have high profit margins, which will support revenue growth as production capacity is released [1] - The projected net profit for 2025 to 2027 is 1.85 billion yuan, 2.00 billion yuan, and 2.82 billion yuan, with respective year-on-year growth rates of 52.54%, 7.99%, and 41.34% [2]

Core Viewpoint - The company, Ningbo Suobao Protein Technology Co., Ltd., anticipates a significant increase in net profit for the year 2025, projecting a rise of 46.89% to 57.62% compared to the previous year [2][3]. Group 1: Performance Forecast - The company expects to achieve a net profit attributable to shareholders ranging from 178 million to 191 million yuan for the year 2025, an increase of 56.81 million to 69.81 million yuan compared to the previous year [2][3]. - The projected net profit, excluding non-recurring gains and losses, is estimated to be between 171 million and 182 million yuan, reflecting an increase of 61.41 million to 72.41 million yuan year-on-year [2][3]. Group 2: Previous Year Performance - In the year 2024, the company reported a total profit of 144.08 million yuan and a net profit attributable to shareholders of 121.18 million yuan [5]. - The net profit after excluding non-recurring gains and losses for 2024 was 109.59 million yuan [5]. Group 3: Reasons for Performance Increase - The anticipated growth in 2025 is attributed to the company's focus on high-end manufacturing improvements, energy optimization, and lean management, which have led to significant cost reductions in production and operations [7]. - The management team has effectively monitored raw material market trends to capitalize on procurement opportunities, successfully lowering the costs of non-GMO soybean purchases [7].

Core Viewpoint - The company Sobo Protein has announced its 2025 annual performance forecast, expecting a significant increase in net profit compared to the previous year [1] Financial Performance - The company anticipates a net profit attributable to shareholders ranging from 178 million to 191 million yuan for 2025 [1] - This represents an increase of 56.81 million to 69.82 million yuan compared to the previous year [1] - The expected year-on-year growth rate is between 46.89% and 57.62% [1]

Core Viewpoint - The company expects significant growth in net profit for the year 2025, with projections indicating an increase of 46.89% to 57.62% compared to the previous year [1] Financial Projections - The estimated net profit attributable to shareholders for 2025 is projected to be between 178 million to 191 million yuan [1] - The estimated net profit after deducting non-recurring gains and losses is projected to be between 171 million to 182 million yuan, reflecting a year-on-year growth of 56.03% to 66.07% [1] Operational Focus - The company is concentrating on high-end manufacturing enhancement, energy optimization, and lean management as key operational strategies for 2025 [1] - Significant achievements have been made in cost reduction and efficiency improvement within production and operations [1] - The management team is closely monitoring raw material market trends to seize procurement opportunities, effectively reducing the cost of non-GMO soybean purchases [1]

Financial Projections - The company expects a net profit attributable to shareholders for 2025 to be between 178 million to 191 million CNY, an increase of 56.82 million to 69.82 million CNY compared to the previous year, representing a year-on-year growth of 46.89% to 57.62%[3] - The projected net profit after deducting non-recurring gains and losses for 2025 is estimated to be between 171 million to 182 million CNY, an increase of 61.41 million to 72.41 million CNY compared to the previous year, indicating a year-on-year growth of 56.03% to 66.07%[5] - In 2024, the company's total profit was 144.08 million CNY, with a net profit attributable to shareholders of 121.18 million CNY, and a net profit after deducting non-recurring gains and losses of 109.59 million CNY[6] - There are no significant uncertainties affecting the accuracy of this earnings forecast[8] - The financial data provided is preliminary and has not been audited, with the final figures to be disclosed in the official 2025 annual report[9] Cost Management and Efficiency - The company achieved significant results in cost reduction and efficiency enhancement through a focus on high-end manufacturing, energy optimization, and lean management[7] - The management team effectively reduced procurement costs for non-GMO soybeans by closely monitoring market trends and seizing purchasing opportunities[7]

致：宁波索宝蛋白科技股份有限公司 关于宁波索宝蛋白科技股份有限公司 2026 年第一次临时股东会的 法 律 意 见 书 康达股会字【2026】第 0017 号 北京市朝阳区建外大街丁 12 号英皇集团中心 8、9、11 层 8/9/11/F, Emperor Group Centre, No.12D, Jianwai Avenue, Chaoyang District, Beijing, 100022, P.R.China 电话/Tel.: 010-50867666 传真/Fax: 010-56916450 网址/Website: www.kangdalawyers.com 北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 南昌 北京市康达律师事务所 北京市康达律师事务所（以下简称"本所"）接受宁波索宝蛋白科技股份有限公 司（以下简称"公司"）的委托，指派本所律师参加公司 2026 年第一次临时股东会 （以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证 ...

证券代码：603231 证券简称：索宝蛋白 公告编号：2026-006 宁波索宝蛋白科技股份有限公司 2026年第一次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 116 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 90,033,674 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 47.0250 | 符合《中华人民共和国公司法》和《公司章程》及其他法律、法规的有关规定， 会议合法有效。 (四) 表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次股东会由公司董事会召集，会议由董事长刘季善先生主持。会议采取现 场投票与网络投票相结合的方式召开。本次股东会的召集、召开、议案审议程序 (一) 股东会召开的时间：2026 年 1 月 16 日 (二) 股东会召开的地点：山东省东营市垦利区华丰 ...

Core Viewpoint - Ningbo Suobao Protein Technology Co., Ltd. has completed the registration of changes in business operations, including the cancellation of the supervisory board and amendments to the Articles of Association [1][2]. Group 1: Corporate Actions - The company's third board meeting and the first extraordinary general meeting of 2025 approved the proposal to cancel the supervisory board and modify the Articles of Association [1]. - The company has completed the business change registration and the filing of the amended Articles of Association with the Ningbo Market Supervision Administration [1]. - Other business registration items recorded in the company's business license have not changed [1].

Group 1 - The core point of the article is that as of January 9, 2026, the number of shareholders for the company Suobao Protein is 16,513 households [2]

特此公告。 宁波索宝蛋白科技股份有限公司董事会 2026 年 1 月 13 日 宁波索宝蛋白科技股份有限公司 关于完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波索宝蛋白科技股份有限公司（以下简称"公司"）第三届董事会第五次 会议和 2025 年第一次临时股东大会，审议通过了《关于取消监事会、修改<公司 章程>的议案》。具体内容详见公司在上海证券交易所网站（www.sse.com.cn）披 露的相关公告。 证券代码：603231 证券简称：索宝蛋白 公告编号：2026-005 近日，公司已在宁波市市场监督管理局完成上述事项的工商变更登记及公司 章程备案工作，本次备案的事项主要为《公司章程》和监事信息变更备案。除上 述事项外，公司《营业执照》记载的其他工商登记事项未发生变更。 ...